Zhang C, Xu C, Gao X, Yao Q. Platinum-based drugs for cancer therapy and anti-tumor strategies. Theranostics. 2022;12:2115–32. https://doi.org/10.7150/thno.69424.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Rottenberg S, Disler C, Perego P. The rediscovery of platinum-based cancer therapy. Nat Rev Cancer. 2020;21:37–50. https://doi.org/10.1038/s41568-020-00308-y.

Article  CAS  PubMed  Google Scholar 

Zhou J, Kang Y, Chen L, Wang H, Liu J, Zeng S, Yu L. The drug-resistance mechanisms of five platinum-based antitumor agents. Front Pharmacol. 2020. https://doi.org/10.3389/fphar.2020.00343.

Article  PubMed  PubMed Central  Google Scholar 

Xue Y, Gao S, Gou J, Yin T, He H, Wang Y, Zhang Y, Tang X, Wu R. Platinum-based chemotherapy in combination with PD-1/PD-L1 inhibitors: preclinical and clinical studies and mechanism of action. Expert Opin Drug Deliv. 2020;18:187–203. https://doi.org/10.1080/17425247.2021.1825376.

Article  CAS  PubMed  Google Scholar 

Ifijen IH, Christopher AT, Lekan OK, Aworinde OR, Faderin E, Obembe O, Abdulsalam-Akanji TF, Igboanugo JC, Udogu U, Ogidi GO, Iorkulak TH, Osayawek OJ. Advancements in tantalum-based nanoparticles for integrated imaging and photothermal therapy in cancer management. RSC Adv. 2024;14:33681–740. https://doi.org/10.1039/D4RA05732E.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Onivefu AP, Efunnuga A, Efunnuga A, et al. Photoresist performance: an exploration of synthesis, surface modification techniques, properties tailoring, and challenges navigation in copper/copper oxide nanoparticle applications. Biomed Mater Devices. 2024;1:1–31. https://doi.org/10.1007/s44174-024-00167-3.

Article  Google Scholar 

Irede EL, Awoyemi RF, Owolabi B, Aworinde OR, Kajola RO, Hazeez A, et al. Cutting-edge developments in zinc oxide nanoparticles: synthesis and applications for enhanced antimicrobial and UV protection in healthcare solutions. RSC Adv. 2024;14:20992–1034. https://doi.org/10.1039/D4RA02452D.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Okonkwo TP, Amienghemhen OD, Nkwor AN, et al. Exploring the versatility of copper-based nanoparticles as contrast agents in various imaging modalities. Nano-Struct Nano-Objects. 2024;40: 101370. https://doi.org/10.1016/j.nanoso.2024.101370.

Article  CAS  Google Scholar 

Omoruyi IC, Omoruyi JI, Aghedo ON, Archibong UD, et al. Application of magnetic iron oxide nanostructures in drug delivery: a compact review. In: TMS 2023 152nd annual meeting and exhibition supplemental proceedings. Cham: Springer; 2023. p. 165–74. https://doi.org/10.1007/978-3-031-22524-6_22.

Khan M, Vikramdeo K, Sudan S, Singh S, Wilhite A, Dasgupta S, Rocconi R, Singh A. Platinum-resistant ovarian cancer: from drug resistance mechanisms to liquid biopsy-based biomarkers for disease management. Semin Cancer Biol. 2021. https://doi.org/10.1016/j.semcancer.2021.08.005.

Article  PubMed  PubMed Central  Google Scholar 

Mcmullen M, Karakasis K, Madariaga A, Oza A. Overcoming platinum and PARP-inhibitor resistance in ovarian cancer. Cancers. 2020. https://doi.org/10.3390/cancers12061607.

Article  PubMed  PubMed Central  Google Scholar 

Waks A, Cohen O, Kochupurakkal B, Kim D, Dunn C, Buendia J, Wander S, Helvie K, Lloyd M, Marini L, Hughes M, Freeman S, Ivy S, Geradts J, Isakoff S, LoRusso P, Adalsteinsson V, Tolaney S, Matulonis U, Krop I, D’Andrea A, Winer E, Lin N, Shapiro G, Wagle N. Reversion and non-reversion mechanisms of resistance to PARP inhibitor or platinum chemotherapy in BRCA1/2-mutant metastatic breast cancer. Ann Oncol Off J Eur Soc Med Oncol. 2020. https://doi.org/10.1016/j.annonc.2020.02.008.

Article  Google Scholar 

D’addario G, Pintilie M, Leighl N, Feld R, Cerny T, Shepherd F. Platinum-based versus non-platinum-based chemotherapy in advanced non-small-cell lung cancer: a meta-analysis of the published literature. J Clin Oncol Off J Am Soc Clin Oncol. 2005;23(13):2926–36. https://doi.org/10.1200/JCO.2005.03.045.

Article  CAS  Google Scholar 

Grønberg B, Sundstrøm S, Kaasa S, Bremnes R, Fløtten O, Amundsen T, Hjelde H, Plessen C, Jordhøy M. Influence of comorbidity on survival, toxicity and health-related quality of life in patients with advanced non-small-cell lung cancer receiving platinum-doublet chemotherapy. Eur J Cancer. 2010;46(12):2225–34. https://doi.org/10.1016/j.ejca.2010.04.009.

Article  CAS  PubMed  Google Scholar 

Lequesne J, Joly F, Péron J, Ray-Coquard I, Hardy-Bessard A, Selle F, Berton D, Follana P, Fabbro M, Lortholary A, Pujade-Lauraine E, Lefèvre-Arbogast S, Coquan E. Evaluation of scores to reflect toxicity impact on quality of life of patients with platinum-resistant ovarian cancer: AURELIA Substudy. J Natl Compr Cancer Netw. 2023;21(5):473-479.e4. https://doi.org/10.6004/jnccn.2022.7101.

Article  CAS  Google Scholar 

Duan Z, Cai G, Li J, Chen X. Cisplatin-induced renal toxicity in elderly people. Ther Adv Med Oncol. 2020. https://doi.org/10.1177/1758835920923430.

Article  PubMed  PubMed Central  Google Scholar 

Zazuli Z, Vijverberg S, Slob E, Liu G, Carleton B, Veltman J, Baas P, Masereeuw R, Zee A. Genetic variations and cisplatin nephrotoxicity: a systematic review. Front Pharmacol. 2018. https://doi.org/10.3389/fphar.2018.01111.

Article  PubMed  PubMed Central  Google Scholar 

Alderden R, Mellor H, Modok S, Hambley T, Callaghan R. Cytotoxic efficacy of an anthraquinone linked platinum anticancer drug. Biochem Pharmacol. 2006;71(8):1136–45. https://doi.org/10.1016/J.BCP.2005.12.039.

Article  CAS  PubMed  Google Scholar 

Desoize B, Madoulet C. Particular aspects of platinum compounds used at present in cancer treatment. Crit Rev Oncol/Hematol. 2002;42(3):317–25. https://doi.org/10.1016/S1040-8428(01)00219-0.

Article  PubMed  Google Scholar 

Oun R, Moussa Y, Wheate N. The side effects of platinum-based chemotherapy drugs: a review for chemists. Dalton Trans. 2018;47(19):6645–53. https://doi.org/10.1039/c8dt00838h.

Article  CAS  PubMed  Google Scholar 

Leal F, García-Perdomo H. Effectiveness of platinum-based chemotherapy in patients with metastatic prostate cancer: systematic review and meta-analysis. Clin Genitourin Cancer. 2019;17(3):e627–44. https://doi.org/10.1016/J.CLGC.2019.03.008.

Article  PubMed  Google Scholar 

Xie P, Wang Y, Wei D, Zhang L, Zhang B, Xiao H, Song H, Mao X. Nanoparticle-based drug delivery systems with platinum drugs for overcoming cancer drug resistance. J Mater Chem B. 2021. https://doi.org/10.1039/d1tb00753j.

Article  PubMed  Google Scholar 

Garcia-Peiro J, Bonet-Aleta J, Santamaría J, Hueso J. Platinum nanoplatforms: classic catalysts claiming a prominent role in cancer therapy. Chem Soc Rev. 2022. https://doi.org/10.1039/d2cs00518b.

Article  PubMed  Google Scholar 

Cheng Q, Liu Y. Multifunctional platinum-based nanoparticles for biomedical applications. Wiley Interdiscip Rev Nanomed Nanobiotechnol. 2017;9:2. https://doi.org/10.1002/wnan.1410.

Article  CAS  Google Scholar 

Cheng H, Wu T, Chien C, Tu H, Cha T, Lin S. Corrosion-activated chemotherapeutic function of nanoparticulate platinum as a cisplatin resistance-overcoming prodrug with limited autophagy induction. Small. 2016;12(44):6124–33. https://doi.org/10.1002/smll.201602374.

Article  CAS  PubMed  Google Scholar 

Oberoi H, Nukolova N, Kabanov A, Bronich T. Nanocarriers for delivery of platinum anticancer drugs. Adv Drug Deliv Rev. 2013;65(13–14):1667–85. https://doi.org/10.1016/j.addr.2013.09.014.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Marques A, Costa P, Velho S, Velho S, Amaral M. Functionalizing nanoparticles with cancer-targeting antibodies: a comparison of strategies. J Control Release Off J Control Release Soc. 2020. https://doi.org/10.1016/j.jconrel.2020.01.035.

Article  Google Scholar 

Bao Y, Hua X, Chen X, Wu F. Platinum-doped carbon nanoparticles inhibit cancer cell migration under mild laser irradiation: multi-organelle-targeted photothermal therapy. Biomaterials. 2018;183:30–42. https://doi.org/10.1016/j.biomaterials.2018.08.031.

Article  CAS  PubMed  Google Scholar 

Zhi S, Zhang X, Zhang J, Wang X, Bi S. Functional nucleic acids-engineered bio-barcode nanoplatforms for targeted synergistic therapy of multidrug-resistant cancer. ACS Nano. 2023. https://doi.org/10.1021/acsnano.3c02009.

Article  PubMed